Hims & Hers Shares Tumble as First Quarter Revenue Forecast Misses Expectations
Hims & Hers shares dropped after the firm projected lower first-quarter sales amid regulatory hurdles. The company remains focused on long-term growth goals.
Insights:
Hims & Hers Health, Inc. issued a first-quarter revenue forecast on February 23, 2026, that fell short of Wall Street expectations, citing significant operational hurdles. The company projected revenue between $600 million and $625 million for the quarter, a range that sits notably below the $653.11 million consensus estimate provided by analysts at LSEG. Following the announcement, the company’s shares declined approximately 7% in after-hours trading as investors reacted to the guidance miss and the underlying business pressures.
